Qingdao Vland Biotech Inc.
603739.SS
Price:
$14.93
Market Cap:
$3.78B
Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products. It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, paper making, hous...[Read more]
Industry
Biotechnology
IPO Date
2019-01-29
Stock Exchange
SHH
Ticker
603739.SS
PE Ratio
[45.24]
ROE
[4.78%]
Current Ratio
[1.08]
Dividend Yield
[0.67%]
Enterprise Value
[4.25B]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Qingdao Vland Biotech Inc. (603739.SS) is 4.25B
According to Qingdao Vland Biotech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.25B. This represents a change of 19.14% compared to the average of 3.57B of the last 4 quarters.
Qingdao Vland Biotech Inc. (603739.SS) Historical Enterprise Value (quarterly & annually)
How has 603739.SS Enterprise Value performed in the past?
The mean historical Enterprise Value of Qingdao Vland Biotech Inc. over the last ten years is 2.93B. The current 4.25B Enterprise Value has changed 14.40% with respect to the historical average. Over the past ten years (40 quarters), 603739.SS's Enterprise Value was at its highest in in the December 2021 quarter at 4.67B. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.
Average
2.93B
Median
3.32B
Minimum
1.60B
Maximum
4.49B
Qingdao Vland Biotech Inc. (603739.SS) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Qingdao Vland Biotech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 131.96%
Maximum Annual Enterprise Value = 4.49B
Minimum Annual Increase = -18.80%
Minimum Annual Enterprise Value = 1.60B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 3.35B | -18.80% |
| 2023 | 4.13B | 11.62% |
| 2022 | 3.70B | -17.67% |
| 2021 | 4.49B | 36.44% |
| 2020 | 3.29B | -13.72% |
| 2019 | 3.81B | 131.96% |
| 2018 | 1.64B | 2.95% |
| 2017 | 1.60B | -0.52% |
| 2016 | 1.61B | -4.30% |
| 2015 | 1.68B | -2.02% |
Qingdao Vland Biotech Inc. (603739.SS) Average Enterprise Value
How has 603739.SS Enterprise Value performed in the past?
The current Enterprise Value of Qingdao Vland Biotech Inc. (603739.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.72B
5-year avg
3.79B
10-year avg
2.93B
Qingdao Vland Biotech Inc. (603739.SS) Enterprise Value vs. Peers
How is 603739.SS’s Enterprise Value compared to its peers?
Qingdao Vland Biotech Inc.’s Enterprise Value is greater than Cabio Biotech (Wuhan) Co., Ltd. (3.81B), greater than Baolingbao Biology Co.,Ltd. (3.49B), greater than Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (3.83B), greater than Shanghai Model Organisms Center, Inc. (3.02B), greater than Yantai Zhenghai Biotechnology Co., Ltd. (3.79B), greater than Zhejiang Wecome Pharmaceutical Company Limited (3.51B), less than Hainan Huluwa Pharmaceutical Group Co., Ltd. (4.70B), greater than Shanghai ZJ Bio-Tech Co., Ltd. (1.49B), greater than Guanhao Biotech Co.,Ltd. (3.86B), less than Shanghai Hile Bio-Technology Co., Ltd. (4.42B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.81B | $3.89B | |
| 3.49B | $3.51B | |
| 3.83B | $3.95B | |
| 3.02B | $3.16B | |
| 3.79B | $3.86B | |
| 3.51B | $3.50B | |
| 4.70B | $3.57B | |
| 1.49B | $3.75B | |
| 3.86B | $3.88B | |
| 4.42B | $4.71B |
Build a custom stock screener for Qingdao Vland Biotech Inc. (603739.SS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qingdao Vland Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Qingdao Vland Biotech Inc. (603739.SS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Qingdao Vland Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Qingdao Vland Biotech Inc.'s Enterprise Value?
What is the highest Enterprise Value for Qingdao Vland Biotech Inc. (603739.SS)?
What is the 3-year average Enterprise Value for Qingdao Vland Biotech Inc. (603739.SS)?
What is the 5-year average Enterprise Value for Qingdao Vland Biotech Inc. (603739.SS)?
How does the current Enterprise Value for Qingdao Vland Biotech Inc. (603739.SS) compare to its historical average?